ZYLö THERAPEUTICS
Zylö Therapeutics offers an innovative sustained-release drug-delivery system that was developed by Joel Friedman MD PhD, Adam Friedman MD FAAD, and Andrew Draganski PhD. The delivery system uses patented hydrogel-derived nanoparticles, called Nanopods, to deliver—in a sustained and controlled manner—notoriously hard-to-deliver therapeutic agents through topical administration. The company was founded in 2017 and is based in Greenville, South Carolina.
ZYLö THERAPEUTICS
Industry:
Health Care Pharmaceutical Therapeutics
Founded:
2017-11-01
Address:
Greenville, South Carolina, United States
Country:
United States
Website Url:
http://www.zylotherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
858.775.6710
Email Addresses:
[email protected]
Total Funding:
13.19 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Google GStatic Google Static Content Google Cloud
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
New York Angels
New York Angels investment in Series B - Zylö Therapeutics
James Cordes
James Cordes investment in Series B - Zylö Therapeutics
Harvard Business School Alumni Angels of Greater NY
Harvard Business School Alumni Angels of Greater NY investment in Series B - Zylö Therapeutics
Cowtown Angels
Cowtown Angels investment in Series B - Zylö Therapeutics
SC Launch, Inc.
SC Launch, Inc. investment in Series B - Zylö Therapeutics
Boston Harbor Angels
Boston Harbor Angels investment in Series B - Zylö Therapeutics
VentureSouth
VentureSouth investment in Series B - Zylö Therapeutics
SC Launch, Inc.
SC Launch, Inc. investment in Grant - Zylö Therapeutics
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases investment in Grant - Zylö Therapeutics
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases investment in Grant - Zylö Therapeutics
Official Site Inspections
http://www.zylotherapeutics.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Zylö Therapeutics" on Search Engine
Zylö Therapeutics - Crunchbase Company Profile
Details. Industries. Health Care. Pharmaceutical. Therapeutics. Headquarters Regions East Coast, Southern US. Founded Date Nov 2017. Founders Scott R. Pancoast. …See details»
Zylö announces the creation and spinout of Atticus …
GREENVILLE, SC, April 17, 2024 (GLOBE NEWSWIRE) -- Zylö recently effected a spinout of Atticus Pharma Inc., whose mission is to unlock the value of the Z-pod ® topical …See details»
Silo Pharma (SILO) and Zylo Therapeutics, Inc. (ZTI) …
Englewood Cliffs, NJ, April 28, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of …See details»
Zylö Therapeutics Closes $5.225 Million Series B Financing
GREENVILLE, SC, June 03, 2022 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., dedicated to developing a transformational drug-delivery platform, announced that it has …See details»
Zylö Receives $600,000 NIH Phase I Grant to Develop a Novel …
Aug 19, 2022 Funds to be used to optimize a formulation and prepare for scale-up and IND-enabling studies GREENVILLE, SC, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Zylö …See details»
Zylö Therapeutics Closes $5.225 Million Series B Financing
Published: Jun 03, 2022. GREENVILLE, SC, June 03, 2022 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., dedicated to developing a transformational drug-delivery platform, …See details»
Zylö Therapeutics Closes $5.225 Million Series B Financing
GREENVILLE, SC, June 03, 2022 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., dedicated to developing a transformational drug-delivery platform, announced that it has …See details»
Zylö Receives $294,000 NIH Phase I Grant to Advance its …
GREENVILLE, SC, May 31, 2023 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the Z-pod ® topical delivery platform, has been awarded a two-year …See details»
Greenville-based Zylo Therapeutics creates spinoff company
Apr 17, 2024 Greenville-based Zylo Therapeutics creates spinoff company. Jason Thomas // April 17, 2024 // Listen to this article. Greenville-based Zylö Therapeutics …See details»
Zylö scoops cash to advance topical delivery particle technology
Jun 7, 2022 Zylö Therapeutics has secured funding to advance its Z-pod topical delivery particles, putting together a $5.2 million series B round to support work on a technology …See details»
Zylö Company Profile: Valuation, Funding & Investors | PitchBook
Nov 17, 2021 Zylo Therapeutics, Llc. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Primary Industry. Drug Delivery. Other …See details»
Zylö Therapeutics Creates Spin-off Company - StartupGVL
Apr 3, 2024 To say Zylö Therapeutics had a big start to 2024 would be an understatement. Not only did the Greenville-founded life sciences startup announce a …See details»
Zylö’s ‘Powered By Z-pod’ Technology Featured in - GlobeNewswire
Sep 27, 2023 About Zylö Therapeutics: Zylö is commercializing the ‘Powered by Z-pod ® ’ technology platform, a disruptive topical delivery system that extends duration of effect, …See details»
Zylö Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
. Zylö Therapeutics offers an innovative sustained-release drug-delivery system. Industries. Health Care, Pharmaceutical. + 1. Headquarters. Greenville, United States. …See details»
Zylö accepted into NYU’s exclusive Endless Frontier Labs
GREENVILLE, SC, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Zylö Therapeutics has been selected to join the Endless Frontier Labs (EFL) 2023-2024 cohort alongside 77 other …See details»
Zylö Therapeutics - Funding, Financials, Valuation & Investors
$13.5M. in funding over 8 rounds. Their latest funding was raised on May 31, 2023 from a Grant round. Zylö Therapeutics is funded by 11 investors. National Institute of Arthritis …See details»
Zylö Therapeutics - Greenville, South Carolina, United States ...
About. Zylö Therapeutics, whose innovative drug delivery system was originally developed at Albert Einstein College of Medicine, partners with companies to solve drug delivery …See details»
Zylö’s ‘Powered by Z-pods®’ technology incorporated into
Feb 6, 2024 About Zylö Therapeutics: Zylö is commercializing the ‘Powered by Z-pod ® ’ technology platform, a disruptive topical delivery system that extends duration of effect, …See details»